恶性肿瘤与去分化学说相关研究与讨论
摘要
恶性肿瘤是一种危害大、较难治的疾病,其发生机制尚未完全解开;当前研究表明,去分化对于恶性肿瘤的发生发展具有一定影响,本文就去分化与恶性肿瘤的发生、发展及治疗等方面作一简要分析。
出处
《生物技术世界》
2015年第8期233-233,共1页
Biotech World
参考文献5
-
1潘小兵,史良俊. 肿瘤发生机制研究现状与展望[J].中国健康月刊,2011,30(5):221-223.
-
2Takahira T, Oda Y, Tamiya S, et al. Alterations of the RBIgene in dedifferentiated liposarcoma. Mod Pathol,2005,18:1461-1470.
-
3汪攀,赵秀文,兰川,吴南.缺氧诱导胶质瘤细胞肿瘤干样细胞形成体外初步研究[J].第三军医大学学报,2015,37(7):616-622. 被引量:4
-
4吕菲菲,杜艳,李楠楠,王玮.三氧化二砷对慢性髓系白血病K562细胞的诱导分化及其作用机制的研究[J].中国实验血液学杂志,2015,23(1):106-110. 被引量:5
-
5Yan M, Zhang Y, He B, et al. IKK α restoration via EZH2suppression induces nasopharyngeal carcinoma differentiation.Nat Commun. 5:3661 doi:10.1038/ncomms4661.
二级参考文献16
-
1Sakai K,Ishikawa Y,Mori Y,et al.A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance:sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis.Inter J Hematol,2011;93(2):237-242.
-
2Shah NP,Nicoll JM,Nagar B,et al.Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib(STI571)in chronic phase and blast crisis chronic myeloid leukemia.Cancer cell,2002;2(2):117-125.
-
3Sells SF,Wood Jr DP,Joshi-Barve SS,et al.Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and-independent prostate cells.Cell growth&differentiation:the molecular biology journal of the American Association for Cancer Research,1994;5(4):457-466.
-
4Bachleitner-Hofmann T,Kees M,Gisslinger H.Arsenic trioxide:acute promyelocytic leukemia and beyond.Leuk Lymphoma,2002;43(8):1535-1540.
-
5Miller WH,Schipper HM,Lee JS,et al.Mechanisms of action of arsenic trioxide.Cancer Research,2002;62(14):3893-3903.
-
6Perkins C,Kim CN,Fang G,et al.Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR,MRP,Bcl-2,or Bcl-x L.Blood,2000;95(3):1014-1022.
-
7Nimmanapalli R,Bali P,O'Bryan E,et al.Arsenic trioxide inhibits translation of mRNA of bcr-abl,resulting in attenuation of Bcr-Abl levels and apoptosis of human leukemia cells.Cancer Res,2003;63(22):7950-7958.
-
8Yuksel S,Saydam G,Uslu R,et al.Arsenic trioxide and methylprednisolone use different signal transduction pathways in leukemic differentiation.Leuk Res,2002;26(4):391-398.
-
9Deleuze V,Chalhoub E,El-Hajj R,et al.TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells.Mol Cell Biol,2007;27(7):2687-2697.
-
10Zhang Y,Payne KJ,Zhu Y,et al.SCL expression at critical points in human hematopoietic lineage commitment.Stem Cells,2005;23(6):852-860.
共引文献7
-
1王建英,杨臻,张坤,许亚梅.中药有效成分拮抗白血病机制评述[J].北京中医药,2016,35(9):890-893. 被引量:3
-
2万文武,汪攀,兰川,吴南.高氧促进胶质瘤干细胞分化致化疗增敏的体外研究[J].中华神经外科杂志,2017,33(3):293-298. 被引量:5
-
3祖璎玲,张莉,周健,韩利杰,赵慧芳,桂瑞瑞,李珍,高松坤,宋永平.干扰素、亚砷酸联合酪氨酸激酶抑制剂治疗原发T315I突变慢性粒细胞白血病一例并文献复习[J].白血病.淋巴瘤,2017,26(5):297-299. 被引量:2
-
4杨茜,杜青容,吴娟丽,李艳艳,王永,白玉盛.中药治疗白血病的研究进展[J].新疆中医药,2019,37(3):86-89. 被引量:4
-
5李海霞,姚旭,田雪飞,龙焱,王跑球.中医药治疗白血病的研究进展[J].中医药导报,2019,25(12):119-123. 被引量:10
-
6杜军,汪攀,龚胜,赵璐,郭海燕,廖彬.HIF1α/HIF2α经EGF调控胶质瘤细胞化疗抵抗机制研究[J].重庆医学,2022,51(8):1261-1265. 被引量:2
-
7周梅,李丹,罗姣,游九红,黄程.高压氧在常见恶性肿瘤治疗中的应用[J].中华航海医学与高气压医学杂志,2023,30(5):684-689.
-
1任峥娟.手术联合放疗治疗子宫内膜癌及卵巢双原发癌的效果观察[J].中国现代医生,2012,50(32):129-130. 被引量:2
-
2石海澄,黄笃高.运用中西医结合治疗胃癌的体会[J].中医药导报,2007,13(12):49-49. 被引量:9
-
3王彩英,张映铭.肺癌脑转移84例临床分析[J].临床肺科杂志,2001,6(3):57-58.
-
4崔越巍,魏孝礼,白玉贤.晚期结直肠癌三线及三线以上治疗的研究进展[J].中国肿瘤,2016,25(7):542-546. 被引量:6
-
5志翔.直肠癌的病变及诊断治疗[J].华夏医药,2007,2(2):142-144.
-
6刘鹏生,臧旺福,鄢凤昌,程士杰.纵隔内平滑肌瘤6例报告[J].哈尔滨医科大学学报,1993,27(1):75-75.
-
7王春娥,李亚军.老年急性白血病误诊14例分析[J].中国全科医学,2006,9(4):325-325. 被引量:1
-
8程凯.小儿胆道胚胎型横纹肌肉瘤1例报告[J].湖北民族学院学报(医学版),2006,23(2):71-71.
-
9黄雪,王秋雁,佘尚扬,唐国都,谭至柔,韦宗萍.24例胃癌合并真菌感染的内镜病理分析[J].临床荟萃,2001,16(13).
-
10李良平,沈通良.原发性胃恶性淋巴瘤误诊分析(附7例报告)[J].医学科技,1994(29):11-12.